Progress in Catheter Ablation: Clinical Application of New Mapping and Ablation Technology
Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized t...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
2001
|
| Schriftenreihe: | Developments in Cardiovascular Medicine
241 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results |
| Beschreibung: | 1 Online-Ressource (XVII, 590 p) |
| ISBN: | 9789401597913 |
| DOI: | 10.1007/978-94-015-9791-3 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046147054 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s2001 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401597913 |9 978-94-015-9791-3 | ||
| 024 | 7 | |a 10.1007/978-94-015-9791-3 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-015-9791-3 | ||
| 035 | |a (OCoLC)1118998620 | ||
| 035 | |a (DE-599)BVBBV046147054 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.12 |2 23 | |
| 084 | |a YR 5000 |0 (DE-625)154117:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Progress in Catheter Ablation |b Clinical Application of New Mapping and Ablation Technology |c edited by Liong Bing Liem, Eugene Downar |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 2001 | |
| 300 | |a 1 Online-Ressource (XVII, 590 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Developments in Cardiovascular Medicine |v 241 | |
| 520 | |a Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results | ||
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Biomedical Engineering and Bioengineering | |
| 650 | 4 | |a Cardiology | |
| 650 | 4 | |a Biomedical engineering | |
| 650 | 0 | 7 | |a Hochfrequenz-Katheterablation |0 (DE-588)4426113-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Hochfrequenz-Katheterablation |0 (DE-588)4426113-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Liem, Liong Bing |4 edt | |
| 700 | 1 | |a Downar, Eugene |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789048158829 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401597920 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781402001475 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-015-9791-3 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031527239 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-94-015-9791-3 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180485875695616 |
|---|---|
| any_adam_object | |
| author2 | Liem, Liong Bing Downar, Eugene |
| author2_role | edt edt |
| author2_variant | l b l lb lbl e d ed |
| author_facet | Liem, Liong Bing Downar, Eugene |
| building | Verbundindex |
| bvnumber | BV046147054 |
| classification_rvk | YR 5000 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-015-9791-3 (OCoLC)1118998620 (DE-599)BVBBV046147054 |
| dewey-full | 616.12 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.12 |
| dewey-search | 616.12 |
| dewey-sort | 3616.12 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-015-9791-3 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03430nmm a2200517zcb4500</leader><controlfield tag="001">BV046147054</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2001 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401597913</subfield><subfield code="9">978-94-015-9791-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-015-9791-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-015-9791-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118998620</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147054</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YR 5000</subfield><subfield code="0">(DE-625)154117:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Progress in Catheter Ablation</subfield><subfield code="b">Clinical Application of New Mapping and Ablation Technology</subfield><subfield code="c">edited by Liong Bing Liem, Eugene Downar</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVII, 590 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Developments in Cardiovascular Medicine</subfield><subfield code="v">241</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedical Engineering and Bioengineering</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedical engineering</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hochfrequenz-Katheterablation</subfield><subfield code="0">(DE-588)4426113-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hochfrequenz-Katheterablation</subfield><subfield code="0">(DE-588)4426113-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liem, Liong Bing</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Downar, Eugene</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789048158829</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401597920</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781402001475</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-015-9791-3</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527239</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-015-9791-3</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046147054 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:31Z |
| institution | BVB |
| isbn | 9789401597913 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527239 |
| oclc_num | 1118998620 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XVII, 590 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | Springer Netherlands |
| record_format | marc |
| series2 | Developments in Cardiovascular Medicine |
| spelling | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology edited by Liong Bing Liem, Eugene Downar Dordrecht Springer Netherlands 2001 1 Online-Ressource (XVII, 590 p) txt rdacontent c rdamedia cr rdacarrier Developments in Cardiovascular Medicine 241 Catheter ablation is widely accepted as an effective and safe form of therapy for cardiac arrhythmia. In many instances this curative procedure is considered as the first line of therapy if not the ultimate treatment of choice. With the use of radiofrequency (RF) modality; which has revolutionized the technology from a barotraumatic, potentially injurious procedure using high voltage, direct-current (DC) shock to a safe and relatively painless one; catheter ablation procedure now carries a very low risk and is extremely effective for certain types of arrhythmia. Its efficacy rate in curing supraventricular tachycardia involving an accessory pathway or dual atrioventricular nodal pathways has been near perfect and its application for certain types of atrial and ventricular arrhythmia have also been very satisfactory. However, conventional RF ablation has several well known limitations, most notably is its ability to only produce relatively small, point lesions; rendering it effective only for an arrhythmia with a small and/or a superficial target. It was soon recognized that the technology would not likely to have significant utility in arrhythmia with a more widespread target such as atrial fibrillation or those which involve scarred and deep myocardial tissue such as ventricular tachycardia. Indeed, the application of conventional RF technology in these complex but common arrhythmia has yielded unsatisfactory results Cardiology Biomedical Engineering and Bioengineering Biomedical engineering Hochfrequenz-Katheterablation (DE-588)4426113-5 gnd rswk-swf Hochfrequenz-Katheterablation (DE-588)4426113-5 s 1\p DE-604 Liem, Liong Bing edt Downar, Eugene edt Erscheint auch als Druck-Ausgabe 9789048158829 Erscheint auch als Druck-Ausgabe 9789401597920 Erscheint auch als Druck-Ausgabe 9781402001475 https://doi.org/10.1007/978-94-015-9791-3 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology Cardiology Biomedical Engineering and Bioengineering Biomedical engineering Hochfrequenz-Katheterablation (DE-588)4426113-5 gnd |
| subject_GND | (DE-588)4426113-5 |
| title | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology |
| title_auth | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology |
| title_exact_search | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology |
| title_full | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology edited by Liong Bing Liem, Eugene Downar |
| title_fullStr | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology edited by Liong Bing Liem, Eugene Downar |
| title_full_unstemmed | Progress in Catheter Ablation Clinical Application of New Mapping and Ablation Technology edited by Liong Bing Liem, Eugene Downar |
| title_short | Progress in Catheter Ablation |
| title_sort | progress in catheter ablation clinical application of new mapping and ablation technology |
| title_sub | Clinical Application of New Mapping and Ablation Technology |
| topic | Cardiology Biomedical Engineering and Bioengineering Biomedical engineering Hochfrequenz-Katheterablation (DE-588)4426113-5 gnd |
| topic_facet | Cardiology Biomedical Engineering and Bioengineering Biomedical engineering Hochfrequenz-Katheterablation |
| url | https://doi.org/10.1007/978-94-015-9791-3 |
| work_keys_str_mv | AT liemliongbing progressincatheterablationclinicalapplicationofnewmappingandablationtechnology AT downareugene progressincatheterablationclinicalapplicationofnewmappingandablationtechnology |